Suppr超能文献

在伴有胫骨干骨折的情况下,使用组织纤溶酶原激活剂治疗冻伤后发生骨筋膜室综合征。

Compartment syndrome following use of tissue plasminogen activator for frostbite in the setting of concomitant diaphyseal tibia fracture.

作者信息

Joseph Noah M, Alfonso Nicholas, Hirschfeld Adam G

机构信息

Department of Orthopaedics, Case Western Reserve University School of Medicine.

Department of Orthpaedic Surgery, MetroHealth Medical Center, Cleveland, OH.

出版信息

OTA Int. 2020 May 22;3(2):e079. doi: 10.1097/OI9.0000000000000079. eCollection 2020 Jun.

Abstract

BACKGROUND

Tissue plasminogen activator (tPA) is a thrombolytic agent increasingly being employed for the treatment of acute frostbite. Although tPA has been shown with success to increase digit salvage rates, data on potential complications, including risk of hemorrhage, is limited. As a result, acute trauma is considered a contraindication to use in many institution-based protocols. Currently, there is a paucity in the literature regarding use of tPA for frostbite in patients with concomitant extremity fractures.

CASE PRESENTATION

We report the case of a 36-year-old male treated with tPA for frostbite to digits of his bilateral hands in the setting of a concomitant diaphyseal tibia fracture. He subsequently developed acute compartment syndrome in his lower extremity. This was followed by emergent fasciotomy and staged fracture fixation with serial wound debridement and subsequent closure. Despite this complication, the patient went on to early radiographic and clinical union of his tibia fracture. His frostbite wounds healed without functional deficits.

CONCLUSIONS

In patients with severe frostbite injury with digital perfusion defects, tPA for thrombolysis may be indicated. Use of thrombolytics for frostbite in trauma patients or those with concomitant extremity fractures requires a multidisciplinary discussion regarding potential risks. Contingency planning is essential to ensure that potential bleeding complications, including development of compartment syndrome, are diagnosed and treated early. Given the paucity in the current literature regarding use of thrombolytics in trauma patients, further study is warranted to inform the surgical community on instances in which the benefits of tPA administration may outweigh the risks.

LEVEL OF EVIDENCE

Case report; Level V.

摘要

背景

组织型纤溶酶原激活剂(tPA)是一种越来越多地用于治疗急性冻伤的溶栓剂。尽管已证明tPA成功提高了手指挽救率,但关于潜在并发症(包括出血风险)的数据有限。因此,在许多基于机构的方案中,急性创伤被视为使用tPA的禁忌症。目前,关于tPA用于伴有四肢骨折患者冻伤治疗的文献较少。

病例介绍

我们报告了一名36岁男性的病例,该患者在伴有胫骨干骨折的情况下,双手手指冻伤接受了tPA治疗。随后他下肢出现急性骨筋膜室综合征。接着进行了紧急筋膜切开术,并分期进行骨折固定,同时进行系列伤口清创和随后的缝合。尽管出现了这种并发症,但患者胫骨骨折仍实现了早期影像学和临床愈合。他的冻伤伤口愈合,未出现功能缺陷。

结论

对于有严重冻伤损伤且存在手指灌注缺陷的患者,可能需要使用tPA进行溶栓治疗。在创伤患者或伴有四肢骨折的患者中使用溶栓剂治疗冻伤,需要就潜在风险进行多学科讨论。应急预案对于确保早期诊断和治疗潜在的出血并发症(包括骨筋膜室综合征的发生)至关重要。鉴于目前关于创伤患者使用溶栓剂的文献较少,有必要进行进一步研究,以便为外科界提供关于tPA给药益处可能超过风险的情况的信息。

证据水平

病例报告;V级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/8022905/c32debbcaefd/oi9-3-e079-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验